Cargando…
Hepatocyte apoptosis is tumor promoting in murine nonalcoholic steatohepatitis
Nonalcoholic fatty liver disease is the most common chronic liver disease and may progress to nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). The molecular determinants of this pathogenic progression, however, remain largely undefined. Since liver tumorigenesis is driven by a...
Autores principales: | Hirsova, Petra, Bohm, Friederike, Dohnalkova, Ester, Nozickova, Barbora, Heikenwalder, Mathias, Gores, Gregory J., Weber, Achim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997423/ https://www.ncbi.nlm.nih.gov/pubmed/32015322 http://dx.doi.org/10.1038/s41419-020-2283-9 |
Ejemplares similares
-
Rho-associated protein kinase 1 inhibition in hepatocytes attenuates nonalcoholic steatohepatitis
por: Dohnalkova, Ester, et al.
Publicado: (2023) -
Death Receptor-Mediated Cell Death and Proinflammatory Signaling in Nonalcoholic Steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2014) -
Vismodegib Suppresses TRAIL-mediated Liver Injury in a Mouse Model of Nonalcoholic Steatohepatitis
por: Hirsova, Petra, et al.
Publicado: (2013) -
Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis
por: Lastuvkova, Hana, et al.
Publicado: (2023) -
Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis
por: Furuta, Kunimaro, et al.
Publicado: (2020)